PLASMA CELL MYELOMA
Clinical trials for PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could four drugs be better than three for myeloma?
Disease control Recruiting nowThis phase 3 trial compares a four-drug combination (daratumumab, bortezomib, lenalidomide, and dexamethasone) against a three-drug regimen (daratumumab, lenalidomide, and dexamethasone) in 1,450 people with newly diagnosed multiple myeloma who are not candidates for early stem c…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for frail myeloma patients: phase III trial tests smarter drug combos
Disease control Recruiting nowThis phase III trial is testing three different drug combinations for people newly diagnosed with multiple myeloma who are considered frail or intermediate-fit and are not getting a stem cell transplant. The study compares three-drug induction regimens followed by either double o…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New cocktail aims to keep High-Risk myeloma at bay
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of belantamab mafodotin, pomalidomide, and dexamethasone can help prevent high-risk myeloma from returning after a stem cell transplant. About 34 patients who have already responded to transplant will receive the drug combo as m…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC
-
New imaging agent could spot hidden myeloma cells
Diagnosis Recruiting nowThis early-stage study tests a new radioactive tracer called [89Zr]DFO-YS5 for PET scans to find multiple myeloma cells that have a specific protein (CD46). About 20 adults with confirmed multiple myeloma will receive the tracer and have a PET scan. The goal is to see if this met…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a tiny dose of radiation ease myeloma bone pain?
Symptom relief Recruiting nowThis study tests whether a very low dose of radiation (2 Gy) can relieve bone pain in people with multiple myeloma that has spread to the bones. The goal is to see if this gentler approach works as well as standard radiation but with fewer side effects and less disruption to chem…
Matched conditions: PLASMA CELL MYELOMA
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could a common allergy pill ease bone pain in myeloma treatment?
Symptom relief Recruiting nowThis early trial is testing whether loratadine, better known as the allergy medicine Claritin, can reduce bone pain caused by a drug called G-CSF in people with multiple myeloma who are having their stem cells collected. The study will compare pain levels between those taking lor…
Matched conditions: PLASMA CELL MYELOMA
Phase: EARLY_PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Simple lifestyle changes and a common heart drug may improve quality of life for myeloma patients
Symptom relief Recruiting nowThis study looks at whether non-chemo approaches like physical activity, intermittent fasting, or adding a beta-blocker (propranolol) can improve immune function and quality of life in people with multiple myeloma or related blood disorders. Researchers will measure changes in im…
Matched conditions: PLASMA CELL MYELOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Brain Radiation's hidden toll: new study tracks memory loss in blood cancer survivors
Knowledge-focused Recruiting nowThis study follows 100 adults with blood cancers (like lymphoma or leukemia) who receive whole brain radiation. Researchers will test memory, thinking, and quality of life over time using MRI scans and questionnaires. The goal is to understand how radiation affects the brain, not…
Matched conditions: PLASMA CELL MYELOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC